Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 321 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 25,154.0 | $234K | 0.07% | +613.0 | +2.5% | $9.31 | -8.5% |
| 322 | PRME | PRIME MEDICINE INC | Healthcare | 66,508.0 | $231K | 0.06% | +2K | +2.5% | $3.48 | -20.0% |
| 323 | — | INHIBRX BIOSCIENCES INC | — | 3,425.0 | $230K | 0.06% | +82.0 | +2.5% | $67.23 | — |
| 324 | ARVN | ARVINAS INC | Healthcare | 21,676.0 | $230K | 0.06% | +528.0 | +2.5% | $10.60 | -16.8% |
| 325 | QURE | UNIQURE NV | Healthcare | 13,977.0 | $229K | 0.06% | +341.0 | +2.5% | $16.35 | +52.1% |
| 326 | — | ATAIBECKLEY INC | — | 63,563.0 | $225K | 0.06% | NEW | — | $3.54 | — |
| 327 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 40,457.0 | $224K | 0.06% | +986.0 | +2.5% | $5.53 | +92.0% |
| 328 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 14,299.0 | $222K | 0.06% | +350.0 | +2.5% | $15.50 | +1.9% |
| 329 | PROK | PROKIDNEY CORP | Healthcare | 123,388.0 | $221K | 0.06% | +3K | +2.5% | $1.79 | -10.0% |
| 330 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 38,030.0 | $221K | 0.06% | +928.0 | +2.5% | $5.80 | +4.6% |
| 331 | VERA | VERA THERAPEUTICS INC | Healthcare | 5,474.0 | $220K | 0.06% | +132.0 | +2.5% | $40.23 | -14.7% |
| 332 | EYPT | EYEPOINT INC | Healthcare | 17,052.0 | $220K | 0.06% | +414.0 | +2.5% | $12.89 | -6.7% |
| 333 | SVRA | SAVARA INC | Healthcare | 39,405.0 | $215K | 0.06% | +962.0 | +2.5% | $5.46 | -7.2% |
| 334 | — | ANGLOGOLD ASHANTI PLC | — | 2,199.0 | $214K | 0.06% | +392.0 | +21.7% | $97.36 | — |
| 335 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 47,095.0 | $211K | 0.06% | +1K | +2.5% | $4.47 | +25.7% |
| 336 | — | ASSEMBLY BIOSCIENCES INC | — | 7,553.0 | $210K | 0.06% | +184.0 | +2.5% | $27.75 | — |
| 337 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 7,016.0 | $209K | 0.06% | +170.0 | +2.5% | $29.85 | -16.8% |
| 338 | CBT | CABOT CORP | Basic Materials | 2,750.0 | $207K | 0.06% | +275.0 | +11.1% | $75.31 | +9.3% |
| 339 | MUR | MURPHY OIL CORP | Energy | 5,007.0 | $207K | 0.06% | -122.0 | -2.4% | $41.25 | -1.8% |
| 340 | SLVM | SYLVAMO CORP | Basic Materials | 4,873.0 | $206K | 0.06% | +2K | +47.0% | $42.24 | -10.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%